CLINICAL_TRIALS
trial_result
· 2017-08-29
Clinical Trial Update: IVM Alone vs ALB + IVM Against Onchocerciasis [Phase 3]
Summary
A Phase 3 trial comparing ivermectin alone versus albendazole plus ivermectin for onchocerciasis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospitals Cleveland Medical Center | Conditions: Onchocerciasis | Phase 3 | Status: COMPLETED